Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/25/2003US6538112 Hybridomas and monoclonal antibodies for an anticoagulant test
03/25/2003US6538111 Monoclonal, humanized antibodies; hybridomas; transformants; use in diagnosis and treatment of chronic bronchial asthma
03/25/2003US6538110 Monoclonal antibodies against the interleukin 2 receptor
03/25/2003US6538106 Compositions and methods for treating infections using analogues of indolicidin
03/25/2003US6538103 Anti-angiogenic agents; kringle 1; use treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, arteriosclerotic plaque formation
03/25/2003US6538028 Method for inhibiting complement activation
03/25/2003US6537982 Method of treating prostatic diseases using active vitamin D analogues
03/25/2003US6537977 Anti-inflammatory agent
03/25/2003US6537973 Treatment and diagnosis of diseases associated with protein kinase C. Oligonucleotides are provided which are targeted to nucleic acids encoding PKC. In preferred embodiments, the oligonucleotides contain one or more chemical modifications.
03/25/2003US6537972 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
03/25/2003US6537968 Treatment of an individual suffering from lupus erythematosus utilizing a serine protease inhibitor. The treatment includes the use of a corticosteroid that is administered separately or in combination. The serine proteases preferred are alpha
03/25/2003US6537967 Treating human immunodeficiency virus infections
03/25/2003US6537966 Follistatin-3
03/25/2003US6537965 Novel parathyroid hormone (PTH) peptide derivatives. In particular, the invention relates to PTH PTH-2 receptor agonist or antagonist properties to the derivatives.
03/25/2003US6537814 Compositions and methods for altering the biodistribution of biological agents
03/25/2003US6537811 SAP-1 (Serum-response factor accessory protein-1); oligonucleotides targeted to nucleic acids encoding SAP-1; use in treatment of cancer; anti-cancer agents
03/25/2003US6537810 Methods for regulating T cell subsets by modulating transcription factor activity
03/25/2003US6537809 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
03/25/2003US6537808 Preservation of eye tissues in culture; obtain tissue, mix with nutrient broth, monitor stability of sample and cultures
03/25/2003US6537806 Compositions and methods for treating diabetes
03/25/2003US6537805 Self-deleting vectors
03/25/2003US6537804 Expression vector comprising a DNA sequence that expresses a peptide of given amino acid sequence which includes tyrosine; use in diagnosis and treatment of leukemia
03/25/2003US6537803 Produced by a recombinant expression vector in a cell; use in pharmacology and drug screening
03/25/2003US6537794 Chemokine
03/25/2003US6537791 Mammalian DNA-dependent ATPase a polypeptides and fusions thereof
03/25/2003US6537785 Methods of treating lysosomal storage diseases
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537781 Methods and compositions concerning canine interleukin 5
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537773 Open reading frames; gene expression; genetic vectors; computer based storage of sequence information; use detection and diagnosis of Mycoplasma
03/25/2003US6537769 Purified and recombinant antigenic protein associated with abdominal aortic aneurysm (AAA) disease, and diagnostic and therapeutic use thereof
03/25/2003US6537768 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens
03/25/2003US6537765 GPR10 as a target for identifying weight modulating compounds
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537754 Association of kinesin with sensitivity to chemotherapeutic drugs
03/25/2003US6537594 Vaccina virus comprising cytokine and/or tumor associated antigen genes
03/25/2003US6537588 Food-induced antisecretory proteins in egg yolk
03/25/2003US6537560 Nucleic acid sequences encoding melanoma antigens recognized by T lymphocytes and protein and peptides encoded by these sequences
03/25/2003US6537556 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537554 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
03/25/2003US6537553 Antagonist to E-selectin mediated cell adhesion to endothe-lial cells; reducing inflammation; inhibiting metastasis by carcinogenic cells
03/25/2003US6537551 Anti-tumor agent comprising salmosin as an active ingredient
03/25/2003US6537550 Preventing bacterial infection of lungs or bronchi in cystic fibrosis patient
03/25/2003US6537549 Cytokine antagonists for the treatment of localized disorders
03/25/2003US6537547 Antitumor agents; side effect reduction even at high dosage
03/25/2003US6537545 Use of corneal hardening agents in enzymeorthokeratology
03/25/2003US6537541 Implantation of HSV-TK retrovirus producer cells to destroy glioma
03/25/2003US6537519 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2257271C Method of isolating cyclosporins
03/25/2003CA2232749C Truncated glial cell line-derived neurotrophic factor
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2125783C Methods for producing thrombin
03/25/2003CA2123108C Human neuropeptide y-y1 receptor
03/25/2003CA2088370C New use of monoclonal antibody
03/25/2003CA2065496C Treatment of aphthous ulcers and other mucocutaneous disorders
03/21/2003WO2002026230A1 Remedies for inflammatory bowel diseases
03/21/2003CA2423423A1 Medecines of ulcerative colitis
03/20/2003WO2003023398A1 Method of screening drug and method of judging significance of mutation in gene encoding transcriptional regulatory factor
03/20/2003WO2003023066A1 Expression profiling in the intact human heart
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023034A2 Regulation of human tau-tubulin kinase
03/20/2003WO2003023025A1 Multiplication of viruses in a cell culture
03/20/2003WO2003023015A2 Method for expression of small antiviral rna molecules within a cell
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023013A2 Novel nucleic acids and polypeptides
03/20/2003WO2003023011A2 Antisense modulation of ribonuclease l expression
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023007A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
03/20/2003WO2003023005A2 Antisense modulation of pka regulatory subunit rii alpha expression
03/20/2003WO2003023004A2 Antisense modulation of fibroblast growth factor receptor 3 expression
03/20/2003WO2003023003A2 Nucleic acid-associated proteins
03/20/2003WO2003023002A2 Novel human proteins, polynucleotides encoding them and methods of using the same
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003023000A2 Linear dna fragments for gene expression
03/20/2003WO2003022998A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022997A2 Human tissue urokinase type plasminogen activator formulation
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022885A1 Chemokines
03/20/2003WO2003022884A2 Methods for construction and screening of libraries of chemokine variants
03/20/2003WO2003022883A2 Use of proteins for the production of a medicament for stimulating the innate non specific immune system
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022875A2 Polymorphisms of pd-1
03/20/2003WO2003022874A1 Antagonist peptides to vegr receptor flt-1
03/20/2003WO2003022871A2 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022862A1 Cct protein expression promoter
03/20/2003WO2003022858A2 Method for screening for inhibitors of protein/protein interaction and corresponding ribozymes
03/20/2003WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003WO2003022312A1 Method for improving oxygen transport by stored red blood cells
03/20/2003WO2003022305A1 Method for treating coumarin-induced hemorrhage
03/20/2003WO2003022304A1 Oxynthomodulin for preventing or treating excess weight
03/20/2003WO2003022303A2 Use of hcg and lh in controlled ovarian hyperstimulation
03/20/2003WO2003022302A2 USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
03/20/2003WO2003022301A2 Use of lh in controlled ovarian hyperstimulation
1 ... 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 ... 3163